Association among blood pressure control in elderly patients with hypertension, left atrial structure and function and new-onset atrial fibrillation: A prospective 2-year study in 234 patients

Hypertension Research

Volumn 36, Issue 9, 2013, Pages 799-806

  Watanabe, Takatomo ^a   Kawasaki, Masanori ^a   Tanaka, Ryuhei ^b   Ono, Koji ^b   Nishigaki, Kazuhiko ^a   Takemura, Genzou ^a   Arai, Masazumi ^b   Noda, Toshiyuki ^b   Watanabe, Sachiro ^b   Minatoguchi, Shinya ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

Author keywords

atrial fibrillation; atrial function; echocardiography

Indexed keywords

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EMPHYSEMA; FEMALE; FLOW RATE; FOLLOW UP; GERIATRIC DISORDER; HEART; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SINUS RHYTHM; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; HYPERTENSION; MALE; PROSPECTIVE STUDIES;

EID: 84883868046     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.25     Document Type: Article

References (27)

1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N. (Pubitemid 28507114)
2. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for arterial fibrillation in a population-based cohort. JAMA 1994; 271: 840-844.
3. Senoo K, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T. Distribution of first-detected atrial fibrillation patients without structural heart diseases in symptom classifications. Circ J 2012; 76: 1020-1023.
4. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part 1: diagnosis, prognosis, and measurement of diastolic dysfunction. Circulation 2002; 105: 1387-1393. (Pubitemid 34260433)
5. Goto S, Ikeda Y, Shimada K, Uchiyama S, Origasa H, Kobayashi HThe J-TRACE investigators. One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. Circ J 2011; 75: 2598-2604.
6. Verdecchia P, Reboldi G, Gattobigio R, Bentivogio M, Bolgioni C, Angeli F, Carluccio E, Sardone MG, Porcellati C. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41: 218-223. (Pubitemid 36204892)
7. Hirose T, Kawasaki M, Tanaka R, Ono K, Watanabe T, Iwama M, Noda T, Watanabe S, Takemura G, Minatoguchi S. Left atrial function assessed by speckle tracking echocardiography as a predictor of new-onset non-valvular atrial fibrillation: results from a prospective study in 580 adults. Eur Heart J Cardiovasc Imaging 2012; 13: 243-250.
8. Ogawa K, Hozumi T, Sugioka K, Iwata S, Otsuka R, Takagi Y, Yoshitani H, Yoshiyama M, Yoshikawa J. Automated assessment of left atrial function from time-left atrial volume curves using a novel speckle tracking imaging method. J Am Soc Echocardiogr 2009; 22: 63-69.
9. Warita S, Kawasaki M, Tanaka R, Ono K, Kojima T, Hirose T, Iwama M, Watanabe T, Nishigaki K, Takemura G, Noda T, Watanabe S, Minatoguchi S. Effects of pitavastatin on cardiac structure and function and on the prevention of atrial fibrillation in elderly hypertensive patients: a prospective study of two-years follow-up. Circ J 2012; 76: 2755-2762.
10. Rahimi K, Emberson J, McGale P, Majoni W, Merhi A, Asselbergs FW, Krane V, Macfarlane PW. PROSPER Executive. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomized controlled trials. BMJ 2011; 342: d1250.
11. Faunchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol 2008; 51: 828-835. (Pubitemid 351255618)
12. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension. Guideline for the management of hypertension for general practitioners. Hypertens Res 2001; 24: 613-634.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group American Society of Echocardiography's Guidelines and Standards Committee European Association of Echocardiography. Recommendation for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463. (Pubitemid 41821197)
14. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983-1992.
15. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Forciea MA, Frishman WH, Jaigobin C, Kostis JB, Mancia G, Oparil S, Ortiz E, Reisin E, Rich MW, Schocken DD, Weber MA, Wesley DJ, Harrington RAACCF Task Force. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011; 123: 2434-2506.
16. The ACCORD study group. Effect of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575-1585.
17. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Prospective studies Collaboration. Lancet 2002; 360: 1903-1913. (Pubitemid 35472129)
18. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high normal blood pressure on the risk of cardiovascular disease. N Eng J Med 2001; 345: 1291-1297.
19. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, Imai Y, Kikuchi K, Ito S, Edo T, Kimura G, Imaizumi T, Takishita S, Ueshima H. For the Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension 2010; 56: 196-202.
20. JATOS study group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008; 31: 2115-2127.
21. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiology 1997; 30: 1527-1533. (Pubitemid 27486472)
22. Stoddard MF, Pearson AC, Kern MJ, Ratcliff J, Mrosek DG, Labovitz AJ. Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans. Circulation 1989; 79: 1226-1236. (Pubitemid 19155757)
23. Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies of Left Ventricular Dysfunction (SOLVD) trials. Circulation 2003; 107: 2926-2931. (Pubitemid 36736634)
24. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlö f B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke complication to atenolol. J Am Coll Cardiol 2005; 45: 712-719.
25. Madrid AH, Bueno MG, Rebollo JM, Mar?́n I, Peña G, Bernal E, Rodriguez A, Cano L, Cano JM, Cabeza P, Moro C. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective and randomized study. Circulation 2002; 106: 331-336. (Pubitemid 34778957)
26. Yamashita T, Inoue H, Okumura K, Kodama I, Aizawa Y, Atarashi H, Ohe T, Ohtsu H, Kato T, Kamakura S, Kumagai K, Kurachi Y, Koretsune Y, Saikawa T, Sakurai M, Sato T, Sugi K, Nakaya H, Hirai M, Hirayama A, Fukatani M, Mitamura H, Yamazaki T, Watanabe E, Ogawa SJ-RHYTHM II Investigators. Randomized trial of angiotensin IIreceptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study). Europace 2011; 4: 473-479.
27. Pérez de Isla L, Balcones DV, Fernández-Golf?́n C, Marcos-Alberca P, Almer?́a C, Rodrigo JL, Macaya C, Zamorano J. Three-dimensional-wall motion tracking: a new and faster tool for myocardial strain assessment: comparison with two-dimensional-wall motion tracking. J Am Soc Echocardiogr 2009; 22: 325-330.